Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020;8(3):116-121.
doi: 10.1007/s40138-020-00218-1. Epub 2020 Jun 16.

Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020

Boris Garber  1 , Jonathan Glauser  1
Affiliations
Review

Recent Developments in Infectious Disease Chemotherapy: Review for Emergency Department Practitioners 2020

Boris Garber et al. Curr Emerg Hosp Med Rep. 2020.

Abstract

Purpose of review: We discuss and review new antimicrobials for treatment of bacterial, viral, fungal, and parasitic infections with indications, contraindications, and side effects for each. We will also review new information and indications on older agents that are relevant to clinical practice. Many of them may be unfamiliar to Emergency Physicians given their newness and at times hospital restrictions on their use. We also review some new promising agents that are not yet in the clinical pipeline.

Recent findings: As new antibiotics become available for clinicians to use, new information becomes available with respect to the drugs' indications, efficacy, pathogen resistance, drug-drug interactions, and side effects.

Summary: This article provides Emergency Department clinicians with a useful summary with new information on antibiotic use and recent research into agents which may become available.

Keywords: Antibiotic; Development; Emergency; Resistance.

PubMed Disclaimer

References

    1. Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi: 10.1016/S1473-3099(17)30753-3. - DOI - PubMed
    1. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369–378. doi: 10.1016/j.jiph.2016.08.007. - DOI - PubMed
    1. Mazer-Amirshahi M, Pourmand A, May L. Newly approved antibiotics and antibiotics reserved for resistant infections: implications for emergency medicine. Am J Emerg Med. 2017;35(1):154–158. doi: 10.1016/j.ajem.2016.10.034. - DOI - PubMed
    1. Hussain M, Galvin HD, Haw TY, et al. Drug resistance in influenza A virus: the epidemiology and management. Infect Drug Resist. 2017;10:121–134. doi: 10.2147/IDR.S105473. - DOI - PMC - PubMed
    1. Banin E, Hughes D, Kuipers OP. Editorial: Bacterial pathogens, antibiotics and antibiotic resistance. FEMS Microbiol Rev. 2017;41(3):450–452. doi: 10.1093/femsre/fux016. - DOI - PubMed